Log on / register
Feedback | Support | My details
A modified human ELISPOT assay to detect specific responses to primary tumor cell targets.
Malyguine A, Strobl SL, Shafer-Weaver KA, Ulderich T, Troke A, Baseler M, Kwak LW, Neelapu SS
J Transl Med 2004 Mar 29, 2:9
[Full text] [PubMed] [Related articles]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.
Boaz MJ, Hayes P, Tarragona T, Seamons L, Cooper A, Birungi J, Kitandwe P, Semaganda A, Kaleebu P, Stevens G, Anzala O, Farah B, Ogola S, Indangasi J, Mhlanga P, Van Eeden M, Thakar M, Pujari A, Mishra S, Goonetilleke N, Moore S, Mahmoud A, Sathyamoorthy P, Mahalingam J, Narayanan PR, Ramanathan VD, Cox JH, Dally L, Gill DK, Gilmour J
Clin Vaccine Immunol 2009 Feb, 16:147-55
[PubMed Central] [PubMed] [Related articles]

2.
Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.
Park HJ, Neelapu SS
Br J Haematol 2008 Jun, 142:179-91
[PubMed Central] [PubMed] [Related articles]

printer friendly 
to  [Help]

© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.